Can the brain’s aging process be slowed? An interdisciplinary team led by UZH psychiatry professor Philipp Homan is investigating this question. The researchers from the universities of Zurich, Basel and Stanford have now received CHF 4 million in funding from the Horten Health Foundation.
An interdisciplinary research consortium aims to determine whether drugs that target metabolism can slow age-related changes in the brain. The project has received CHF 4 million from the Horten Health Foundation through its clinical consortium projects funding program. Philipp Homan, professor of clinical research in psychiatry at the University of Zurich and deputy director at the University Hospital of Psychiatry Zurich (PUK), will lead the project. Over the next four years, he will work with Heike Bischoff-Ferrari of the University of Basel, Flurin Cathomas of PUK and Tony Wyss-Coray of Stanford University on the PROMOTE project.
